image: Monitoring response to treatment in multiple myeloma patients requires a bone marrow biopsy, an invasive and painful procedure. New research shows that a blood test analyzing circulating tumor cells in patients' blood may offer a noninvasive alternative. view more
Credit: Val Altouninan / <i>Science Translational Medicine</i> (2016)